Alcon Inc. logo

Alcon Inc.

TickerALCVenueUSSectorHealthcarePrimary listingBeta0.70
$65.99-0.29%
FinScore63

Alcon Inc. is a Switzerland-based company in the Healthcare sector with a market capitalisation of $32.0B. Its FinScore is 63/100; its highest-scoring layer is Quality (66) and its lowest is Momentum (55). The shares trade at 50.0x trailing earnings and are down 15% year to date.

Market cap
$32.0B
P/E (TTM)
50.0x
Dividend yield (TTM)
0.54%
ROE
2.9%

Share price performance

Loading chart…

About Alcon Inc.

www.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Profile
Sector
Healthcare
Industry
Medical - Specialties
HQ
Switzerland
Fiscal year-end
December
Trading currency
USD
Reporting currency
USD
Fundamentals updated
24 days ago
Market
Market cap
$32.0B
Shares outstanding
483.4M
P/E (TTM)
50.0x
Dividend yield (TTM)
0.54%
Beta (issuer)
0.73
Revenue (latest FY)
$10.4B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall63
Quality66
Growth58
Value56
Momentum55
Relative Strength90

Snapshot

Ownership

As of 2026-06-30
Institutional
49.4%
Insider
—
Free float
99.7%
Top-5 institutional holders
12.1%
Shares outstanding
483.4M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Alcon Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.